Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.74% | $ 472.08M | $ 3.5M |
3/31/2025 | -1.23% | $ 527.73M | $ 6.5M |
12/31/2024 | -0.68% | $ 1.22B | $ 8.3M |
9/30/2024 | -18.02% | $ 1.9B | $ 342.5M |
6/30/2024 | -20.33% | $ 1.86B | $ 378M |
3/31/2024 | -15.96% | $ 2.35B | $ 375M |
12/31/2023 | -11.46% | $ 3.27B | $ 374.7M |
9/30/2023 | -4.13% | $ 978.9M | $ 40.4M |
6/30/2023 | -0.28% | $ 1.3B | $ 3.7M |
3/31/2023 | -0.27% | $ 1.35B | $ 3.7M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ARVINAS INC is calculated as follows: (-1 * CF - Equity [ $ 141.81M ]) / Market Cap [ $ 902.21M ]
(=) Buyback Yield [ -15.72% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |